Bridge to heart transplantation using the Levitronix CentriMag short-term ventricular assist device.

@article{Sef2020BridgeTH,
  title={Bridge to heart transplantation using the Levitronix CentriMag short-term ventricular assist device.},
  author={Davorin Sef and Prashant N Mohite and Fabio de Robertis and Alessandra Verzelloni Sef and Balakrishnan Mahesh and Ulrich Stock and Andr{\'e} Ruediger Simon},
  journal={Artificial organs},
  year={2020}
}
Heart Transplantation in Adult Congenital Heart Disease with the Organ Care System Use: A 4-Year Single-Center Experience
TLDR
In the experience, despite the challenges of transplantation in ACHD, these patients can be successfully transplanted with the use of the OCS in a highly specialized center and careful donor and recipient selection are of paramount importance.
Valvular complications following the Impella device implantation
Despite clear clinical benefits, there is limited evidence regarding possible complications of the novel mechanical support device Impella. Aortic and mitral valve regurgitation or injury are rare

References

SHOWING 1-4 OF 4 REFERENCES
Novel minimally invasive surgical approach using an external ventricular assist device and extracorporeal membrane oxygenation in refractory cardiogenic shock
  • K. Takeda, A. Garan, H. Takayama
  • Medicine, Engineering
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • 2017
TLDR
The authors' minimally invasive surgical approach using an external VAD is a feasible strategy for patients with cardiogenic shock who are refractory to percutaneous short-term MCS support.
Refractory heart failure dependent on short-term mechanical circulatory support: what next? Heart transplant or long-term ventricular assist device.
TLDR
Patients with rapid deterioration in chronic advanced heart failure refractory to medical treatment need inotropic support and may need intra-aortic balloon pump to maintain circulatory support, which of course cannot be prolonged beyond a certain limit.
CentriMag short-term ventricular assist as a bridge to solution in patients with advanced heart failure: use beyond 30 days.
  • P. Mohite, B. Zych, A. Simon
  • Medicine, Engineering
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • 2013
TLDR
CentriMag proved to be a versatile, safe and effective short-term circulatory support for patients with advanced heart failure as a bridge to solution and its use over 30 days is associated with acceptable survival and does not increase device-related complications.
Bridge to decision using the Levitronix CentriMag short-term ventricular assist device.
  • F. de Robertis, P. Rogers, E. Birks
  • Medicine
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
  • 2008